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EFFECTS OF PATIENT FACTORS ON IMPLANTATION RATES IN 
IN VITRO FERTILIZATION 
Heidi Richardson 
Sofia Soto 
Abstract  
The purpose of this report is to evaluate the effects of patient factors and embryo quality 
on the implantation rate in In Vitro Fertilization (IVF). For this report, statistical methods are 
used to test the significance of several patient and embryo characteristics on embryo 
implantation rate. This project is an analysis of data collected from over 36,000 patients.  
The analysis concluded several findings. There was enough statistical evidence to 
conclude that age was significant in regards to implantation rate and FSH levels. As the patient 
ages, the amount of FSH levels found in their blood increases. A patient with high FSH levels 
produces less oocytes than a patient with a lower FSH level.  A low number of oocytes produced 
will in return yield a lower implantation rate. When body-mass index and smoking preference 
were analyzed, the analysis showed that the null hypothesis could not be rejected. When looking 
at embryo morphology, they played a significant role within percentile groups. The most 
significance was shown within the embryos that were transferred in day 5. These conclusions 
support the fact that since embryos are graded as good quality depending on their morphology, 
any improvements can be seen through the improvement of this selection process.  
There are several direct and indirect costs that result from IVF treatments. These treatments are 
very costly ranging from $16,000 - $800,000, and can represent a significant economic burden for 
families. Besides having a monetary impact, IVF procedures also have a great psychological impact on 
patients. Undergoing an IVF treatment can greatly affect a patient's emotional, physical, and relational 
status. 
 4 
 
Introduction 
By using various statistical methods, the purpose of this report is to expose and 
understand the patient factors that affect In Vitro Fertilization (IVF) performance that may 
potentially contribute to an increased success rate and reduce variation in the process. The 
human body and this process are so complex that it is impossible to ignore the effects that a 
patient has on the type of embryo that is produced, or how the clinics method of growing 
embryos can affect the type of embryo that is produced. This report is going to focus on the 
patient factor aspect and will have a design analysis around blocking the effect of the clinics and 
embryo types. The principle patient factors that will be covered in this report are whether the 
patient was a smoker or not, their age, Follicle Stimulating Hormone (FSH) levels, and their 
Body-Mass Index (BMI) score.  A detailed study of the following objectives will be analyzed in 
this report: 
● Investigate the effect of patient’s age on Implantation Rate 
● Investigate the effect of patient’s smoking preference on Implantation Rate 
● Investigate the effect of patient BMI on implantation Rate 
● Investigate the effect of patient FSH level on implantation Rate 
● Analysis of age effecting FSH level in patient’s blood 
● Analysis of FSH levels effecting number of oocytes produced 
● Analysis of implantation rate by percentile clinics on embryo types 
● Analysis of implantation rate effect on number of oocytes retrieved 
 A master’s thesis is currently being conducted encompassing the two factors this report 
will not cover (Clinic Percentile and Embryo Morphology).  Based on the results of this study, 
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the statistically significant patient factors will help create a better process to improve success 
rates in the lower percentile clinics. 
The proposal for this experiment stemmed from Dr. Alex J. Steinleitner's clinic located in 
San Luis Obispo, which specializes in In-Vitro Fertilization. Currently, some clinics around the 
US, including his, have a success rate of over 70 percent while others are closer to 30 percent. 
Dr. Steinleitner wants to find assignable causes for variation between clinics and implement 
process controls to increase the success rate of the underperforming clinics. In order to achieve 
any conclusions, a wide range of data is necessary to begin the analysis phase.  IVF clinics 
throughout the United States have accumulated data for 3 years, in order to make this experiment 
possible. The data includes but is not limited to the woman’s age, embryo score, donor egg/non 
donor egg. 
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Literature Review 
History of IVF 
              The search for a cure to infertility has long been researched since 1855 when Dr. J. 
Marion Sims believed that infertility could be cured through gynecological surgery or artificial 
insemination.  Nearly 30 years later the first child was born through artificial insemination by 
physician William Pancoast. After this achievement, success in the field of assisted reproductive 
technology progressed slowly. It wasn’t until 1968 that British scientist Robert Edwards teamed 
with Patrick Steptoe and fertilized the first human eggs in vitro. Over the next nine years, the 
public analyzed the ethics behind this discovery. In December of 1977 the British team 
successfully grew an egg fertilized in vitro in a human uterus and on July 25 of 1978 their work 
was official with the delivery of baby Louise Joy Brown. Since then, in vitro fertilization has 
become a part of medical vernacular and over 450 IVF clinics have opened across the United 
States (pbs.org). 
 
The IVF Process 
Normally, in order to conceive a baby, an egg and sperm are fertilized inside a woman’s 
body. If the fertilized egg attaches to the lining of the womb and continues to grow, a baby is 
born about 9 months later. This process is called natural or unassisted conception (Storcke).  
Unfortunately, about 10% of women ages 15-44 in the United States have difficulty getting 
pregnant or staying pregnant (Infertility). For this precise reason, Sir Robert Edwards was the 
first pioneer of in-vitro fertilization (IVF) in 1978 (Johnson). IVF is a form of reproductive 
assisted technology that helps a woman become pregnant and is usually chosen when other less-
expensive fertility techniques have proven to be unsuccessful because IVF itself is so expensive.   
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There are five basic steps to IVF. The first one is the stimulation step, also known as 
superovulation. In this step, the patient is given drugs to stimulate her ovaries and develop 
multiple eggs, since most women usually produce only one egg per month. Step two is called 
Egg Retrieval. Once the eggs are mature, a minor surgery called follicular aspiration is 
performed to remove the eggs from the ovaries. During this procedure, a needle is placed 
through the vaginal opening and into the ovaries containing the eggs. The needle is then 
connected to a suction device that pulls the eggs out of each follicle, one at a time. The eggs then 
get transferred to an embryology lab where they are evaluated for maturity.  More on how to 
evaluate the eggs will be discussed further in the literature review. Step three which is called 
fertilization in the Lab is what comes next. At this stage, a fresh sample of sperm is collected in 
which the best sperm is chosen for insemination. The sperm is placed together with the best 
quality eggs and stored in a controlled chamber. If the doctor believes the chance of fertilization 
is low, the sperm is then injected directly into the egg using a process called intra-cytoplasmic 
sperm injection (ICSI).  If the fertilization is successful, the oocytes and embryos will stay in the 
lab for about 2-5 days (Keefe). 
The next two steps are very important because they dictate which embryo will be the 
most qualified to be transferred. Step four is called embryo culture/quality. During this step, the 
laboratory staff will regularly check the embryo to ensure that it is growing properly. Once a 
good embryo is identified, they are transferred during day 3 or day 5. Day 3 embryos are called 
cleavage stage embryos and have about 4-8 cells. Day 5 embryos are called blastocyst embryos 
and look like a ball of cells with liquid inside. The last step is called Embryo Transfer. This is the 
stage in which the embryos are placed inside the woman’s uterus through her vagina. It is a 
simple procedure that does not require anesthesia. During the process, the embryos are loaded 
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into a thin tube called a catheter, and then inserted into the woman’s vagina.  Pregnancy results if 
an embryo sticks inside the lining of the womb and grows (Keefe). 
It is possible to insert more than one embryo into the womb to have twins, triplets, or more. This 
however is a complex issue that depends on several factors including a woman’s age. The 
embryos that are not used may be frozen and implanted or donated on a later date (Storcke). 
 
Cleavage Stage (Day 3) vs. Blastocyst Stage (Day 5) Embryos 
Embryos from assisted reproductive technologies in vitro fertilization (IVF), are usually 
transferred into the woman’s uterus at either the early cleavage stage (Day 2 to 3 after egg 
collection) or blastocyst stage (Day 5 to 6 after egg collection). Currently, doctors’ majority 
opinion is that transferring embryos at the blastocyst stage is the most biologically correct stage 
for embryos to be in the uterus since earlier stages are naturally in the fallopian tube (Wang). 
They also benefit from the embryo staying in the laboratory longer, since it may give doctors 
more time to select the best quality embryo(s). The objective of this experiment was to evaluate 
whether the live birth rate and other pregnancy outcomes can be improved by Day 5 to 6 transfer 
compared with Day 2 to 3 embryo transfer (Wang). 
The experiment consisted of seven trials (n=1446 cases). The results confirmed that 
blastocyst transfer was statistically significantly associated with an increase in clinical pregnancy 
rate with an odds ratio (OR) of 1.43% and confidence interval (CI), 1.15-1.78], implantation rate 
(OR 1.38; 95% CI, 1.09-1.74) and ongoing pregnancy rate (OR 2.15; 95% CI, 1.57-2.94), and 
also a reduction in the probability of first trimester miscarriage rate (OR 0.51; 95% CI, 0.30-
0.87). The improvement in the live birth rate was also observed to have (OR 1.77; 95% CI, 1.32-
2.37) (Wang). 
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The above experiment results suggest that indeed, live birth rate and other pregnancy 
outcomes are significantly improved if the embryo is transferred during the blastocyst stage 
compared to the cleavage stage. 
 
Quality: Defined 
              Currently, most labs use embryo morphology as the main quality indicator. It is a 
noninvasive embryo selection technique that has been utilized since the early days of IVF. Of 
course, this method has its limitations and room for error. Morphological assessments are not 
always performed at constant time intervals, thus making variations in the score. For example, an 
embryo scored early on day 2 can appear significantly different than the same embryo late on 
day 2. The cell could morph from a 2-cell to a 4-cell during that time period, making this method 
fairly crude and subjective (Montag, Toth, Strowitzki). 
              The main points that are analyzed in this widely used method include: fragmentation 
percentage, the number of cells, shape of the cells at all days, and the appearance of the zona 
pellucida, inner cell mass and trophectoderm of the blastocyst at day 5 (SART). Another study, 
performed in 1999, found the characteristics that led to the highest pregnancy success. The 
“characteristics of these top quality embryos were absence of multinucleated blastomeres, four or 
five blastomeres on day 2, seven or more cells on day 3, and ≤20% anucleated fragments” (van 
Royen). 
            Presently, it is known that the quality of the embryo can only be as good as the woman 
carrying it. There are many factors that influence the success of IVF. Still, isolating the quality of 
the embryo is a significant factor used to predict the success of the procedure. 
 
 
 
 S.A.R.T. Embryo Scoring System 
There have been numerous grading systems created to rank embryos in the processes 
utilized in Assisted Reproductive Technology (ART) labs. Some systems use the overall 
appearance of the cleavage stage embryo, others at the blastocyst stage, and some are more 
complex that involve formulas to predict the possibility of pregnancy. Embryo quality has been 
correlated with pregnancy success, and without having data of each emb
variability in success rates occurred. Because of this diverse grading system and lack of a 
convention, comparisons between clinics and overall quality control could not be performed. In 
2004, “embryo morphology fields” were included in the
Technologies (SART) database (Racowsky). After this incorporation, SART developed their 
own grading/scoring system which was made mandatory to include by March 2010. This system 
had 3 goals: to be “1) simple, 2) comprised 
some proven predictive value, and 3) easily adopted in laboratories not routinely capturing these 
parameters” (Racowsky). The following three
  
 
 
 
 
 
 
 
 
Table 1: SART Grading System (
 
 
ryo score, high 
 Society of Assisted Reproductive 
of fields that have a basis in scientific inquiry with 
-point system (Table 1) was developed:
Source: Racowsky) 
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Since SART has mandated that embryo score be included in all datasets, much more accurate 
predictions have been made in predicting pregnancy. 
A study was conducted to evaluate the correlation between the SART scoring method and 
ART single blastocyst embryo transfers. In the study, each blastocyst was given a grade based on 
the SART scoring system and then statistical methods such as multiple logistic regression and 
chi square analysis were used to correlate the scoring system to live birth rate. The study used a 
sample of 717 single blastocyst transfer cycles that were fresh and autologous (Heitmann). 
“The live birth rate was 52 % and included both elective and non-elective [single blastocyst 
cycles] SBT. Chi square analysis showed higher live birth in good grade embryos as compared to 
fair (p = 0.03) and poor (p = 0.02). Univariate binary logistic regression analysis demonstrated 
SART embryo grading to be significantly correlated with both implantation and live birth (p <
0.01). This significance persisted when patient age, BMI, and the stage of the blastocyst were 
controlled for with multiple logistic regression. In five patients with a poor blastocyst score, 
there were no live births” (Heitmann). 
From this study it can be seen that the SART grading method is a strong indicator in live 
birth success and should be used when analyzing any ART data. 
To test if SART’s grading method accounted for all factors influencing success in an 
embryos morphology, Sophia Kamran, ET. Al. devised a study to see whether or not the 
symmetry of the day 3 embryo was a significant predictor to pregnancy in addition to the 3 main 
areas that the SART method uses: cell number, fragmentation and blastomere symmetry. In the 
study, Kamran used MATLAB to measure the “roundness” of a day 3 embryo. Using statistical 
methods, she found that this characteristic was not useful as an additional marker for embryo 
selection. This finding helped to show the appropriateness of the SART grading system in 
correlation with pregnancy success.    
The NYU Langone Medical Center states that there is no standard classification system 
for all fertility centers. Although most centers use the Gardner grading system for blastocysts, 
 12 
 
each center created their own system for grading day-2 and 3 embryos as the technology 
developed and, at this point, it would be too difficult for all centers to try and use a standard 
grading method (NYU Langone Medical Center). For this reason, all data that is used in this 
research is collected in the same database using the same methodology. Only clinics using the 
SART grading method have contributed data. 
Factors Influencing IVF Success: 
Several external factors have been identified in reducing the success of IVF pregnancies; 
ethnicity, smoking, age, patient Body Mass Index (BMI), and paternal BMI. 
Ethnicity 
Since IVF is a fairly new concept, there are many factors that could be contributing to 
unsuccessful pregnancies. Most scientists have researched and experimented with the age of the 
patients to see if this plays a major role in whether the process is successful. It is important 
however, to take into account all of the possible variables that can influence the outcome of IVF 
such as ethnicity. Can ethnicity be an influence on IVF? This is the question that a team of 
researchers at Nottingham University in the UK set out to answer. 
              Ethnic minorities form a significant portion of couples undergoing (IVF) throughout the 
world. It is important to let these patients know what their probabilities of success may be based 
on their genetic makeup and variables that might affect their outcome. There have already been a 
number of reports published on the relationship between ethnicity and IVF success. Asian 
infertile women in the United States were reported to have a lower IVF success rate compared 
with white woman (Jayaprakasan). 
              In other studies in the US, authors have reported that white woman also have more 
biochemical pregnancies and live births compared to women from ethnic minorities. Including 
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but not limited to Hispanic and Asian. In the UK, studies that were published in the late 1990’s 
reported that in the USA, South Asian Indian women had lower live birth rates when compared 
to white woman despite their younger age and lower basal follicle stimulating hormone (FSH) 
(Jayaprakasan).A follicle stimulating hormone is an acidic glycoprotein found in women that 
stimulates the development of ovarian follicles (eggs) and stimulates the release of estrogen. In 
men, this hormone stimulates the production of sperm (Follicle). 
In this particular study, the team aimed to investigate the relationship between ethnicity 
and IVF outcome in a large population that received treatment over a period of five years 
between 2006 and 2011. The IVF outcome between minorities and subpopulation groups such as 
South-East Asian, African-Caribbean, and Middle Eastern were compared to white European 
groups. For this particular study, all women who participated were undergoing their first cycle of 
IVF treatment to try and reduce variability. The study was performed in the UK at the 
Nottingham University Research and Treatment Unit in Reproduction. All of the patients 
underwent a standard long agonist or antagonist protocol, depending on their ovarian reserve 
tests. The difference between these two protocols is the time in which the patient received the 
gonadotrophin-releasing hormone. For the long agonist protocol, the gonadotrophin is started in 
the midluteal phase of the menstrual cycle while during the antagonist protocol, it is commenced 
on day two. The starting doses of gonadotropin were dependent on the woman’s age and ranged 
from 150-450 iu. The women were then monitored for follicle development with a serious of 
transvaginal ultrasound beginning on the fifth or sixth day of simulation. As soon as the doctors 
noticed three follicles measuring more 18mm or more in diameter, oocyte retrieval was 
performed 36 hours later. The oocytes are then fertilized in the lab and depending on the number 
of embryos that developed, a maximum of two embryos was transferred into the uterus at days 2, 
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3, or 5 after insemination.  All of the pregnant women were followed up to record accurately the 
final outcome of their pregnancies (Jayaprakasan). 
The data was then recorded in a Microsoft Excel spreadsheet and analyzed using various 
statistical methods. Their first step was to test for normality to choose the appropriate statistical 
test. Continuous data was analyzed by the Student T-test or by the U-test, depending on the data 
distribution. The Chi Square test and Fisher were performed to analyze the relationship between 
two categorical variables. Out of the 1517 women who began the treatments, 23 did not reach the 
egg-retrieval stage, 11 developed an excessive response, 5 had no eggs to be collected, 9 had no 
mature eggs, 39 failed fertilization, and 1395 had embryo transfer. Their results on a univariate 
logistic regression analysis, was that ethnicity was an independent predictor of live birth rate 
with a p-value of less than or equal to .02.  On a regression analysis, ethnicity proved to not be a 
predictor of successful IVF outcome only when the South-East Asian population was included in 
the population with a p-value of .06 (Jayaprakasan). 
Based on the experiment, the data indicate that live birth rates, clinical pregnancy rates, 
and implantation rates followed by IVF are significantly lower in ethnic groups when compared 
to European women. It proves that ethnicity may be a major determinant of live birth following 
IVF treatment. When the subgroups were analyzed, success rates were lower in the South-East 
Asian, African-Caribbean, and Middle-Eastern groups but not statistically significant possibly 
because of the small group sizes. It is important to tell patients realistically, what their 
probabilities are of having a positive outcome.  Although this research indicated that ethnicity 
affects the probabilities of a successful outcome, further research is needed to know the degree of 
variation in success caused by different ethnic backgrounds. There may be modifications 
 available to the clinical strategies of IVF to ensure equivalent success rates among all ethnic 
groups when the relationship between ethnicity and IVF outcomes are thoroughly understood.
Age 
JunHao Yan, et al., conducted a retrospective, observational study of 11,830 IVF
vitro fertilization embryo transfer) cycles. The women were aggregated into four age groups, 21
30, 31-35, 36-40, and 40+. Many factors were analyzed in the study, including; the
Gonadatropin, mean number of oocytes received, 2PN zygote rates, good quality embryo rates, 
clinical pregnancy rates, miscarriage rates, and birth defect rates. The following graphic shows 
the significant findings: 
 
Figure 1: IVF Outcomes of Different Maternal Age Groups
Source: Yan, JunHao, KeLiang Wu, Rong Tang, LingLing Ding, and Zi
Maternal Age on the Outcomes of in Vitro Fertilization and Embryo Transfer (IVF
Science China Life Sciences, 55.8 (2012): 694
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The findings were interesting in that age does not seem to play a factor in the quality of 
day 3 embryos and 2PN zygote rates. However, the tests showed significant findings of lower 
pregnancy rates in those of increasing age, as well as miscarriage rate. The miscarriage rates 
match those of natural pregnancy though, and thus other factors such as uterine anatomical 
defects, environmental factors obesity, endometriosis, etc can be in effect. The study concluded 
that age significantly plays a role in IVF success, and pregnancy in general. The authors state 
that women 21 through 30 years of age will have the best IVF outcomes of the women of fertile 
age (Yan). 
A similar study conducted at the Reproductive Medicine Center of the Third Affiliated 
Hospital of Guangzhou Medical College by Hong-zi Du, et. al, looked at the effects of patient 
age, and number and quality of transferred embryos. The study grouped the infertile women into 
three age groups, <30, 31-34, and >=35. The results found that it is desirable to select a single 
good-quality embryo for patients <30 and two good-quality embryos for women >30. As women 
age, poor-quality embryos should not be transferred at all, and more than two good-quality 
embryos may need to be transferred (Du). 
Body Mass Index 
Obesity is also considered to be a factor influencing the success of IVF treatment. Not 
only does the patient’s Body Mass Index (BMI) affect the dosage of gonadotropins, but it can 
also have effects on the reproductive tissues and organs, leading to increases in maternal and 
neonatal complications (Bellver).  A retrospective analysis was performed by D.K. Shah, et al., 
on the effect of BMI on IVF outcomes. The results were presented as odds ratios (OR) and 
confidence intervals. Eight hundred ninety-three women were studied with varying BMIs. Those 
with Class II and III obesity (BMI of 35.0-39.9 and >=40.0, respectively) had much lower peak 
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estradiol levels (2123 pg/mL vs. 1664 and 1366, p<0.05), fewer oocytes retrieved (15 vs. 11 and 
12, p<0.0001), and fewer total embryos (14 vs. 11 and 12, p<0.0001). Women with Class III 
obesity also had lower live birth rates (OR=0.4, CI = 0.18-0.88) and a 29% greater incidence of 
immature oocytes (CI = 1.11-1.81) compared to subjects with normal BMI (18.5-24.9) (Shah). 
Another study that accounts for obesity and BMI includes Zaher O. Merhl et al.’s article 
on male adiposity and how it affects clinical pregnancy rates but not the day 3 embryo quality 
score. Merhl and company retrospectively studied 344 infertile couples, focusing on several 
areas: the number of oocytes retrieved, zygote PN-score, total number of embryos available on 
day 3, number of embryos transferred, composite day 3 grade for transferred embryos, composite 
day 3 grade per cycle, and CPR. The results found one hundred twenty-one cycles resulted in 
clinical pregnancy (35.2%). The normal BMI category was associated with a much higher CPR 
(46.7%) than that of the overweight and obese BMI categories (32.0% averaged CPR). There 
were no significant differences in any of the other factors analyzed. The study concluded that, 
“embryo grading based on conventional morphologic criteria does not explain the poorer clinical 
pregnancy outcomes seen in couples with overweight or obese male partners” (Merhl). 
Tobacco Smoking 
Cigarette smoking is widely believed to be associated with decreased fecundity outcomes 
in naturally conceiving populations. The effect of female smoking on pregnancy outcomes in 
patients undergoing IVF however is still unclear and over the last few decades, smoking among 
women of reproductive age has increased. Lifestyle habits such as smoking may indeed play a 
crucial role in the success rates of IVF. Tobacco smoke contains hundreds of substances 
including but not limited to nicotine, carbon monoxide, and mutagens. There have been 16 
studies all divided into retrospective studies, prospective studies, and meta-analysis that have 
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investigated the effect of smoking on IVF (Kettel). In almost all of these studies, smoking did not 
uniformly affect the same endpoints. The studies showed that maternal smoking decreased 
fertilization rates, number of oocytes, pregnancy rates, and increased miscarriage rates. In other 
studies there was no effect of smoking on fertilization and pregnancy rates. Other studies simply 
just did not have the adequate power to assess significant differences in pregnancy outcomes. 
The biggest mistake in some of these was not defining the smoking history of each patient with 
sufficient details. Smoking was classified when patients first entered the study, but not 
throughout the procedure where their habits may have changed. Women who stopped smoking 
cigarettes after commencing the treatment were classified as current smokers given that their 
habits had changed (Seibel).   
The study conducted by Hilary Klonoff-Cohen, Loki Natarajan, Richard Marrs, and Bill 
Yee focused on evaluating all biological and reproductive endpoints. It involved both females 
and males and also performed multivariate analyses and adjusted for potential confounders and 
interaction terms. The quantity, frequency, and duration of smoking was also carefully taken into 
account. The study included 221 couples undergoing IVF treatment in Los Angeles, Orange and 
San Diego counties. All subjects were between the ages of 20-40 years old and the subjects over 
35 years old were analyzed separately because of an increase incidence of miscarriage. The 
smoking habits were categorized by the following time periods: lifetime, 1 year, 1 month, 1 
week, and one day prior to the procedure. In addition, all of the patients smoking habits were 
monitored throughout the entire procedure (Kettel). 
When conducting multivariate analyses, the RR for not achieving pregnancy was 2.41 
with a p-value of .03 for smoking compared with non-smoking couples. There was a 40% 
decrease in the number of oocytes aspirated from smoking couples during the IVF treatment. Of 
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the 41 couples who had successful live birth deliveries, 11 had multiple births. The smoking 
effects on the multiple births were assessed using a logistic regression. For multiple deliveries, 
there was a 9% higher RR for each additional year that the person smoked before being treated 
with IVF. The data also concluded that if a woman ever smoked during her lifetime, her risk of 
not having a successful pregnancy increased by 9% per year that the individual smoked. In 
conclusion, the above study provides compelling evidence that smoking negatively affects the 
probabilities of a successful pregnancy outcome (Kettle). 
There have been a lot of studies showing how smoking can affect a successful live birth 
when undergoing an IVF treatment, but can second hand smoking also affect a successful 
outcome? Secondhand tobacco smoke (STS) is a mixture of over 4000 chemicals, where more 
than 60 of them are known or suspected carcinogens or reproductive toxins (Lindbohm). In a 
previous study, self-reported female STS exposure was associated with decreased implantation 
and pregnancy rates among the 225 women tested undergoing IVF (Neal). The increasing use of 
assisted reproductive technology, in particular IVF, has helped improve doctor’s abilities to 
study contributing factors that lead to infertility and early pregnancy loss. Follicle Fluid also 
stated as FF, is the fluid that surrounds the preovulatory oocyte. It is collected during IVF 
treatment but very seldom used although it has the potential to serve as a matrix to measure 
markers of exposure to STS or other environmental agents. The amount of cotinine levels in FF 
are an indicator of a developing oocytes direct exposure to tobacco (Fabro). 
The following study was designed to examine the relationship between female STS 
exposure and failed implantations using the cotinine dosages in FF in women undergoing IVF. 
The study used women who had an IVF treatment from 1994-2003 at one of three Boston clinics. 
The total number of participants was 1909 couples with a total of 3270 treatment cycles. The 
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physicians and technicians retained the FF from the participants during egg retrieval for each 
cycle. The FF was aspirated from the follicles using a 16 G needle and suction from a Rocket 
pump apparatus and then transferred to a petri dish. The fluid, which would normally be 
discarded at this point, was placed into a 15 ml tube and centrifuged for 15 minutes. After, it was 
transferred to the Brigham and Women’s hospital laboratory for analysis (Benedict, Stacey). 
The data analysis was performed using SAS software where cotinine concentrations were 
recorded. The study established that the cycles with STS exposed would yield FF cotinine 
concentrations of <10 and >1.1 ng/ml and unexposed cycles were < 1.11 ng/ml. The potential 
confounding variables were female age, BMI, ethnicity, primary infertility diagnosis, site of 
treatment, months spent trying to get pregnant, etc. (Homer). The results showed a significant 
increase in the risk of failed implantation among women exposed to STS in comparison to those 
unexposed. Based on a 95% CI with a p-value of .004, it was concluded that there is also a 
relationship between STS exposure and IVF treatment success. In an analysis among 921 women 
who had urine samples available for cotinine measurement, creatinine-adjusted cotinine levels in 
urine were associated with a slight decrease in first-cycle implantation rates among non-smoking 
women (11.1% in the lowest cotinine quintile versus 8.2% in the highest quintile; P = 0.13 
(Meeker). 
In conclusion, this study found a significant increase in the risk of implantation failure 
among women exposed to STS compared with those who were unexposed based on cotinine 
concentrations measured in the FF of the women. They also found a significant decrease in the 
odds of achieving a successful live birth among STS-exposed women. 
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Breakthroughs and Obstacles 
IVF doctors and scientists have been at the top of fertility research and treatment since 
the first successful IVF birth in Australia. This procedure is nowhere near perfect and there is 
always room for improvement as well as new side effects surfacing. As of now there is not a 
standardized procedure to determine the quality of an IVF procedure. There are still many 
variables that can affect the number and quality of oocytes and embryos in patients. 
Recent research done by Dr. Rinchen Zangmo the Departments of Obstetrics and 
Gynecology in New Delhi, India has evaluated the role of dehydroepiandrosterone (DHEA) on 
the number and quality of oocytes and embryos in patients who have not been successful with 
IVF cycles. To better understand the experiment done by Dr. Zangmo, it is crucial to have an 
understanding of what DHEA really is. DHEA is a hormone that is naturally made by the human 
body, specifically the adrenal gland and brain (Zangmo). This hormone leads to the production 
of androgens and estrogens in both males and females. Although the human body produces 
DHEA, scientists have now also found a way to synthetically produce it with chemicals found in 
wild yam and soy. It is important to note that the human body cannot produce this hormone by 
simply eating wild yam and soy. 
              For this experiment, a total of 50 patients with a record of poor ovarian response in the 
previous IVF cycles participated. The patients were categorized into two different age groups, 
where half of them were under 35 and the other half were over 35 years of age. They were 
treated with 25 mg of DHEA three times a day for a period of four months. The oocyte and 
embryo number and quality were recorded before and after the four months and then analyzed 
using a student paired T-test. The results showed an increase of mature oocytes after the 4 month 
period of DHEA treatment with patients under 35 having a P<.001 and patients over 35 years of 
age yielding a P = 0.002. There were significant increases in the total number of oocytes 
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retrieved, fertilization rates, thus increasing the number of embryos available (Zangmo). In 
conclusion, DHEA can help improve pregnancy rate in poor responders with history of previous 
failed IVF cycles. 
              Since there are various factors that may contribute to the successful outcome of IVF 
treatment, it is important to have a deep understanding of past experiments conducted in these 
areas. Furthermore, identifying and understanding the important considerations and analysis that 
have been made in past research is crucial. The studies on these topics will help the team have a 
thorough understanding of the topics to provide pertinent analysis and assessment to this 
research project.  
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Design and Methods  
Set-Up 
 
The data that was used for this project was purchased by Dr. Steinleitner and provided by 
the Society of Reproductive Technologies (SART) and collected over 3 years. The data included 
over 36,800 patients and had a description of every single patient’s age, smoking status, BMI, 
FSH level, embryo morphology, day of transfer, number of oocytes retrieved, number implanted, 
number of beating hearts, and live births. The data was initially organized by percentile clinic 
and patient ID, with each patient’s embryo types being grouped together. To be able to analyze 
each embryo individually, the data was stacked using Microsoft Excel so that each embryo 
morphology was a unique entry. See Appendix A Table 2 for an example of the stacking before 
and after process. Embryo morphology encompasses the data of the embryo that includes the day 
in which the embryo was transferred, the stage it was in, and many other characteristics 
depending on whether it was transferred on day 3 or day 5.   
 After this filtering step, the number of entries increased from approximately 36,000 to 
73,651.   Once the embryos were stacked accordingly, the next step in having useful data for our 
analysis was to filter out the cases of embryos that would not be of any value to the study. The 
only cases that were useful were those in which all embryos were successful or not. For example 
if two embryos were transferred and two embryos implanted, then it could be implied that both 
embryos were successful and could trace the characteristics for each one. In the cases where the 
number of embryos transferred was greater that the number that implanted, it was impossible to 
determine which one of those embryos were the ones that implanted. After filtering the data for a 
second time, the final number of embryos that were analyzed were approximately 53,000. The 
 implantation rate of each embryo was then calculated by dividing the number of implantations by 
the number of embryos transferred. 
 
The next phase in this project was to identify the questions that needed to be answered 
and realize what patient factors could potent
that shows the relationships that were 
                                                  Figure 3
Once the areas of interest were created, the next step in this process was to group all of 
the data to make it categorical and analyze it on JMP.  Since the age of the patients ranged all the 
way from 17 to 52 years of age, grouping the data made for the analysis to be m
manageable. According to a previous study made by Dr. Steinleitner, t
Figure 2, shows the steps taken to create our useful data. 
Figure 2: Data Processing Stages 
ially affect each other. Figure 3 below i
analyzed between patient factors and implantation rate. 
: Patient Factor and IR Relationships Analyzed 
uch more 
he best groups to separate 
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age by were, under 36, between 36 and 39, and over 39 years-old. Clinic percentiles were also 
split into 3 groups composed of percentiles 1-30, 40-60, and 70-90.  After all of the data was 
filtered and grouped, Microsoft Access was used to easily maneuver through the large data set. 
 
Patient Factors 
To begin the analysis, several questions were brainstormed to be the basis of the study. 
The subject matter can be difficult to comprehend initially and these simply stated questions 
helped to clarify what was being researched. The first question that was sought to be answered 
was, “Does the patient’s age, BMI or smoking preference have a significant effect on 
implantation rate?”  Before running any statistical test, a few key assumptions had to be met.  
Since the data for implantation rate fell in between 0 and 1, the normality assumption could not 
be met. In order to normalize the data, a nominal logistic model was used. After reaching 
normality and testing for constant variance, the model was applied.  From Figure 4, the three-
factor model is shown to be significant with a chi-squared value of less than 0.001.  The Effect 
Likelihood Ratio Tests table shows that smoking and BMI cannot be concluded to contribute 
significantly to the model fit. The report shown in this three-factor model supports the 
conclusion that age is the only factor that has an effect on embryo implantation rate. It is evident 
based on these results that as a patient gets older, the probabilities of implantation decrease.  
 
 
 
Figure 4: Nominal Logistic Model for Implantation Rate 
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The graph below (Figure 5) shows the relationship between IR and age of the patient. It also 
shows that based on these conclusions the largest quantity of patients who undergo an IVF 
treatment are patients over 32 years of age. 
 
Since smoking preference and BMI could not be proven significant, the effects of only 
patient’s age on other factors possibly influencing implantation rate were studied. This brought 
about the second question, “Does age play a significant role in the patients FSH blood levels?”  
FSH is one of the most important hormones involved in the natural menstrual cycle as well as in 
pharmacological (drug-induced) stimulation of the ovaries. It is the main hormone involved in 
producing mature eggs in the ovaries.  
Figure 5: IR by Age 
 Figure 6, shows the one way ANOVA that was used to compare the means of the FSH 
grouping using the F distribution. The data below shows that the constant variance assumption 
was met. 
 
 
 
 
 
 
The one way ANOVA in Figure 7, 
less than 0.001 in determining the amount of FSH levels in the patient. The connecting letters 
report shows that all FSH level groups were significant. As the patients get older, they will yield 
higher levels of FSH than younger patients. 
 
 
 
 
Figure 7: One Way ANOVA with Letters Report of Age Group and FSH
Figure 6: One Way ANOVA of Max FSH by Age Group
concludes that the patient’s age was significant with a p
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-value 
 To build upon these results, the correlation between FSH levels and number of oocytes 
produced were studied. In a regression model, it was found that the maximum FSH level in the 
patients’ blood was significant (with a p
to be retrieved. The best-fit line does not fit this data well (R
does show the overall trend of the data, indicating some inverse proportionality.
Response Number
Figure 8: Scatter Plot of Number of Oocytes versus FSH Levels
-value of < 0.0001) in predicting the number of oocytes 
-Square value of only 0.06), but 
 
 Oocytes Retrieved 
Regression Plot 
 
 
Figure 9: Regression Analysis 
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 Finally, the last question to be answered was, “Does the number of oocytes produced 
affect the embryo implantation rate?” For this question, the 
grouped into categories as deemed correct by our professional, clinical reference, Dr. 
Steinleitner. The categories assigned were, less than 6, between 6 and 35, and greater than 35. As 
the data shows, the constant variance assumption was met. 
From the one way ANOVA, the p
than 99%. The connecting letters report 
significant and the mean implantation rate decreases as the number of oocytes decrease.
numbers of oocytes retrieved were
 
Figure 10: Constant Variance Plot 
-value for the model was significant at a level greater 
shows that each grouping of oocytes retrieved are
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 Figure 11: One way ANOVA with Letters Report of IR and Oocyte Groupings 
Embryo Quality 
After producing as many conclusions from the given categories of patient factors data as 
possible, the focus moved to determining how embryo morphology quality affected implantation 
rate across percentiles. Percentiles were grouped by categories (for ease of analysis) 1st 
percentile, 40 – 60th, 70 -90th percentile clinics. To select which embryo groupings were most 
beneficial to study, a contingency table was created for each morphology type and 
implantation rate for each patient factor. Those groupings with the highest implantation rates 
were selected for study. For this analysis, only the youngest age grouping (under 36 years of age) 
was used, for ease of analysis and because this group 
on implantation rate.  See Appendix B
contingency table, the following groups were selected for study: Expanded Blastocyst, Good 
Inner Cell Mass (ICM), Good Trop
has the least repercussions of age’s effect 
 Table 3, for the full contingency table.  From the 
hectoderm; Hatching Blastocyst, Good ICM, Good 
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-30th 
its unique 
 Trophectoderm; 8-cell, 0 Fragmentation,
Perfect Symmetry. 
The following analysis shows the implantation rate of Day 5 Expanded Blastocysts with 
Good Inner Cell Mass and Good Trophectoderm across percentile groupings. 
Figure 12
 Perfect Symmetry; 8-cell, 1-10% Fragmentation, 
 
: Constant Variance of Percentile Groupings 
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 Figure 13: ANOVA of IR and Percentile Grouping (Day 5)
Figure 
The model is found to be significant with a p
performing clinics yielding more successful implantation rates.  An Expanded Blastocyst in a 70
90th percentile clinic has an average 
has an average IR of 0.276 (std. error of 0.01394) in a 1st
An analysis was also conducted for the day 5 hatching Blastocysts with Good Inner Cell 
Mass and Good Trophectoderm across percentile groupings. 
variance was met. 
 
14 : Letters Report of Day 5 Embryo 
-value of less than 0.0001, showing higher 
IR of 0.391 (std. error of 0.00764) while the same embryo 
-30th percentile clinic. 
Figure 15 shows that constant 
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-
 
 Figure 15
 
Figure 16: ANOVA of Day 5 Hatching Blast with Letters Report
 
: Constant Variance of Day 5 Hatching Blast 
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 The model is not found to be significant
compared, the null hypothesis cannot be rejected. When looking at percentile clinics individually 
in the connecting letters report from Figure 16, the groupings with 
percentiles are significant. A Hatching Blast
.427 (std. error of 0.0065) while the same e
0.01245) in a 1st-30th percentile c
dependent on morphology and percentile gr
consistent with clinical knowledge that higher performing clinics tend to have better technology 
that enables them to grow day 5 embryos, while 
support day 5 embryos.  
The Day 3 analysis began
Again, an ANOVA test was conducted to detect significance between percentile groupings.
 
 
 
 
 
 
 
 
Figure 
 
1
 meaning that when all three percentile means
1-30th percentiles and 70
 in a 70-90th percentile clinic has an average IR of
mbryo has an average IR of 0.337 (std. error of 
linic.  A full table on each embryo’s implantation rate 
ouping can be found in Appendix C. 
lower performing clinics lack the techn
 with 8-Cell, 0 Fragmentation, Perfect Symmetry embryos. 
 
17: Constant Variance of Day 3 Embryo 
-30 40-60 70-90 
Percentile 
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 are 
-90th 
 
This finding is 
ology to 
 
 Figure 
From the results, the model is significant with a p
groupings are not completely independent.
Figure 
Some overlap can be found between the mid
group has a mean IR of 0.1785 (std. error of 0.00935) and the lower performing clinics a mean 
IR of 0.1355 (std. error of 0.01081
18: ANOVA Analysis of Day 3 Embryo 
-value of 0.0087. The three percentile 
 
19: Letters Report of Day 3 Embryo 
-level percentiles. The higher performing clinic 
). 
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 The next day 3 embryo that was analyzed was an 8 cell, 1
symmetry. The data was tested for constant variance and passed. The ANOVA test in Figure 20 
below showed that he model was significant with a p
that all three percentile groupings are not independent within this particular embryo morphology.
 
 
 
 
 
 
 
 
 
 
 
 The higher performing clinic group for this 8 cell embryo has a mean IR of 0.125 
0.00468) and the lower performing clinics a mean IR 
Clinically, the closeness in performance of embryos with day 3 transfers makes sense. All clinics 
are able to produce day 3 embryos. In practice, the hi
embryos on day 3 if the embryo quality of the patient is low and incubating the embryo any 
further will most likely not yield a high quality embryo.
of each embryo morphology analyzed on JMP.
 
-10% fragmentation, perfect 
-value less than .001. In this case it
Figure 20: Anova of Day 3 Embryo 
of 0.078665 (std. error of 0.01623).
gher performing clinics will only transfer 
 See Appendix D for an in depth analysis 
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(std. error of 
 
 Cost Analysis 
The IVF process is extremely intensive, both financially and socially, therefore direct and 
indirect costs must be taken into account. 
Direct Costs 
Patients want to spend the least amount of money possible for the best 
both the upfront price of a procedure, and the number of treatments need to be considered. A 
high-ranked clinic may charge $10,000 per treatment while a lower
$7,000 per treatment. Even though the upfront
the end, because the success rate is lower in the cheaper clinic, the patient may need several 
rounds of IVF accumulating two or three times the amount of the upfront costs.  The following 
table illustrates this simple model:
A high-ranking percentile clinic can charge more for their process, because of their higher IR and 
success rate. These treatments are very costly ranging from $16,000 
significant economic burden for families. 
can increase benefits for the clinic and patient, in increased revenue and less trials, respectively.
 
 
possible results. For IVF, 
-ranked clinic may charge 
 costs of the lower percentile clinic is cheaper, in 
 
 
Table 2: Cost Comparison 
- $800,000, and often represent a 
Therefore, making small improvements to their process 
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Indirect Costs 
For women, the pregnancy process is extremely emotional. Hoping for a positive result 
can be draining, and receiving a negative result, simply earth-shattering. The stress of an 
unfulfilled wish for a child has been associated with emotional symptoms such as anger, 
depression, anxiety, and feeling of worthlessness. Some patients have rated the stress of 
undergoing an IVF cycle as more stressful than or just as stressful as another major life event 
such as the death of a family member, separation, or divorce. Physically woman are exposed 
most of the time to various rigorous rounds of medications and injections. Patients have said it is 
more stressful and uncomfortable to undergo an IVF cycle than a normal menstrual cycle. 
Despite the relatively low chance of achieving pregnancy in one IVF cycle, many women have 
unrealistic expectations about the treatment success. Many women report a lack of control during 
the process and feel like they have little choice but to succumb to the invasive investigations. As 
a result of this, feelings of depersonalization can occur.  
Undergoing infertility treatments can also have an impact on a patient’s social life. Social 
activities are often put on hold because many women are not able or willing to share their 
experiences. Furthermore the frequent hospital visits can result in missing a lot of work days. It 
can also put a strain on relationships since partners cope with these situations differently. 
Overall, IVF treatments put a lot of stress on the patients and their families both psychologically 
and financially. Any improvements in the success rate of IVF cycles would greatly benefit 
patients and clinics. 
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Results and Discussions  
In summary, age is significant with regards to implantation rate and FSH level.  FSH 
level played an important role in the number of oocytes retrieved, which in turn plays a large role 
in determining Implantation success. Also, the older the patient becomes, the higher the 
maximum FSH blood level will be which in turn is significant in making the implantation rate 
lower. When analyzing whether smoking and BMI were significant regarding implantation, the 
null hypothesis could not be rejected.  Lastly, Embryo Morphology was significant across 
percentile groups, especially within day 5. This means that the process used to grow embryos is 
significant in determining an implantation rate. 
 As stated in the cost analysis section, increasing the implantation rates of the lower 
performing clinics could save patients a lot of money and potentially reduce the amount of cycles 
a woman undergoes. Each cycle has proven to be mentally and physically straining for each 
patient. They can be a negative impact on relationships and even cost them their jobs. 
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Future Directions  
 The amount of information included in this dataset is enormous. There are many areas 
that can be expanded upon. Several of these areas, such as differences between percentile groups 
and across embryo morphology are being researched for a Master’s thesis. The results of the 
mentioned thesis are expected to be a breakthrough in IVF. By studying differences between 
percentile groups and embryo morphology, a standardized grading method/scale are hoped to be 
produced, along with conclusions about the different processes clinics are using. 
Also, using this report as a baseline, expanding implantation rate to live birth rate success 
would be an interesting step. This could reveal more effects that the patient has on the successful 
completion of growing the fetus. Perhaps then, a significance can be seen in BMI and smoking 
preference of the patient. 
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Appendix A 
Before      
Percentile 
Group 
Patient ID Age BMI Embryo 
Morphology 
1 
Embryo 
Morphology 
2 
70 11111111 34 24.3 Early Blast, 
Good 
Hatching 
Blast, Good 
50 1232123 37 25.7 8-cell, 0% 
Frag 
8-cell, 1-10% 
Frag 
 
After      
Percentile Patient ID Age BMI Embryo 
Morphology 
MOVED 
70 11111111 34 24.3 Early Blast, 
Good 
 
70 11111111 34 24.3 Hatching 
Blast, Good 
 
50 1232123 37 25.7 8-cell, 0% 
Frag 
 
50 1232123 37 25.7 8-cell, 1-10% 
Frag 
 
Table 3: Stacking Process 
 
 
 
 
 
 
 
 
 
 
 Appendix B 
Table 4: Embryo morphology Contingency Tables 
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 Appendix C 
Table 5: Percentile Grouping Contingency Table by Embryo Morphology
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 Appendix D 
One way Analysis of IR By Percentile 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Oneway Anova 
Summary of Fit 
  
Rsquare 
Adj Rsquare 
Root Mean Square Error 
Mean of Response 
Observations (or Sum Wgts) 
 
Analysis of Variance 
Source  DF
Percentile  2
Error  3709
C. Total  3711
 
Means for Oneway Anova 
Level Number Mean 
1 607 0.276085 
2 1083 0.318252 
3 2022 0.390620 
 
 
Means Comparisons 
Comparisons for each pair using Student's t
Confidence Quantile 
t Alpha 
1.96060 0.05 
 
1-30 
– Day 5 Exp. Blast – Good 
 
0.017394 
0.016864 
0.343392 
0.350777 
3712 
 Sum of Squares Mean Square F Ratio 
 7.74195 3.87098 32.8277 
 437.35775 0.11792  
 445.09970   
Std Error Lower 95% Upper 95% 
0.01394 0.24876 0.30341 
0.01043 0.29779 0.33871 
0.00764 0.37565 0.40559 
 
40-60 70-90 
Percentile 
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Prob > F 
<.0001* 
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LSD Threshold Matrix 
Abs(Dif)-LSD 3 2 1 
3 -0.02117 0.04702 0.08338 
2 0.04702 -0.02893 0.00803 
1 0.08338 0.00803 -0.03865 
 
Positive values show pairs of means that are significantly different. 
 
Connecting Letters Report 
 
Level             Mean 
3 A        0.39061985 
2   B      0.31825177 
1     C    0.27608457 
 
Levels not connected by same letter are significantly different. 
 
Ordered Differences Report 
Level  - Level Difference Std Err Dif Lower CL Upper CL p-Value  
3 1 0.1145353 0.0158928 0.0833758 0.1456948 <.0001* 
3 2 0.0723681 0.0129305 0.0470165 0.0977197 <.0001* 
2 1 0.0421672 0.0174110 0.0080310 0.0763034 0.0155* 
 
 
 
Oneway Analysis of IR By Percentile Day 5 – Hatching- G-G 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Oneway Anova 
Summary of Fit 
   
Rsquare 0.009245 
Adj Rsquare 0.007108 
Root Mean Square Error 0.37822 
Mean of Response 0.37043 1-30 
40-60 
70-90 
Percentile 
1-30 40-60 70-90 
Percentile 
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Observations (or Sum Wgts) 930 
 
Analysis of Variance 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
Percentile 2 1.23743 0.618714 4.3251 0.0135* 
Error 927 132.60773 0.143050   
C. Total 929 133.84516    
 
Means for Oneway Anova 
Level Number Mean Std Error Lower 95% Upper 95% 
1 425 0.404706 0.01835 0.36870 0.44071 
2 292 0.363014 0.02213 0.31958 0.40645 
3 213 0.312207 0.02592 0.26135 0.36307 
 
Std Error uses a pooled estimate of error variance 
 
Means and Std Deviations 
Level Number Mean Std Dev Std Err 
Mean 
Lower 95% Upper 95% 
1 425 0.404706 0.370965 0.01799 0.36934 0.44008 
2 292 0.363014 0.392238 0.02295 0.31784 0.40819 
3 213 0.312207 0.372955 0.02555 0.26183 0.36258 
 
Means Comparisons 
Comparisons for all pairs using Tukey-Kramer HSD 
Confidence Quantile 
q* Alpha 
2.34748 0.05 
 
LSD Threshold Matrix 
Abs(Dif)-HSD 1 2 3 
1 -0.06091 -0.02579 0.01796 
2 -0.02579 -0.07348 -0.02920 
3 0.01796 -0.02920 -0.08603 
 
Positive values show pairs of means that are significantly different. 
 
Connecting Letters Report 
 
Level             Mean 
1 A       0.40470588 
2 A B     0.36301370 
3   B     0.31220657 
 
Levels not connected by same letter are significantly different. 
 
Ordered Differences Report 
Level  - Level Difference Std Err Dif Lower CL Upper CL p-Value  
1 3 0.0924993 0.0317520 0.017962 0.1670364 0.0102* 
2 3 0.0508071 0.0340807  -0.029197 0.1308109 0.2958 
1 2 0.0416922 0.0287487  -0.025795 0.1091791 0.3157 
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Oneway Analysis of IR By Percentile Day 3 – 8 cell – 0 - Perf 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Oneway Anova 
Summary of Fit 
   
Rsquare 0.006125 
Adj Rsquare 0.004838 
Root Mean Square Error 0.242918 
Mean of Response 0.15778 
Observations (or Sum Wgts) 1548 
 
Analysis of Variance 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
Percentile 2 0.561819 0.280910 4.7604 0.0087* 
Error 1545 91.169458 0.059009   
C. Total 1547 91.731278    
 
Means for Oneway Anova 
Level Number Mean Std Error Lower 95% Upper 95% 
1 505 0.135479 0.01081 0.11428 0.15668 
2 368 0.150344 0.01266 0.12551 0.17518 
3 675 0.178519 0.00935 0.16018 0.19686 
 
Std Error uses a pooled estimate of error variance 
 
Means Comparisons 
Comparisons for all pairs using Tukey-Kramer HSD 
Confidence Quantile 
q* Alpha 
2.34597 0.05 
1-30 40-60 70-90 
Percentile 
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LSD Threshold Matrix 
Abs(Dif)-HSD 3 2 1 
3 -0.03102 -0.00875 0.00951 
2 -0.00875 -0.04201 -0.02419 
1 0.00951 -0.02419 -0.03586 
 
Positive values show pairs of means that are significantly different. 
 
Connecting Letters Report 
 
Level             Mean 
3 A       0.17851852 
2 A B     0.15034420 
1   B     0.13547855 
 
Levels not connected by same letter are significantly different. 
 
Ordered Differences Report 
Level  - Level Difference Std Err Dif Lower CL Upper CL p-Value  
3 1 0.0430400 0.0142924 0.009511 0.0765694 0.0074* 
3 2 0.0281743 0.0157408  -0.008753 0.0651017 0.1733 
2 1 0.0148657 0.0166494  -0.024193 0.0539245 0.6449 
 
 
 
Oneway Analysis of IR By Percentile – 8 Cell – 1-10%- Perfect 
 
 
 
Oneway Anova 
Summary of Fit 
   
Rsquare 0.024008 
Adj Rsquare 0.022236 
Root Mean Square Error 0.24011 
Mean of Response 0.140121 
Observations (or Sum Wgts) 1105 
 
Analysis of Variance 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
Percentile 2 1.562800 0.781400 13.5535 <.0001* 
Error 1102 63.533517 0.057653   
C. Total 1104 65.096317    
 
Means for Oneway Anova 
Level Number Mean Std Error Lower 95% Upper 95% 
1-30 305 0.090164 0.01375 0.06319 0.11714 
40-60 503 0.178595 0.01071 0.15759 0.19960 
70-90 297 0.126263 0.01393 0.09893 0.15360 
 
Std Error uses a pooled estimate of error variance 
1-30 40-60 70-90 
Percentile 
 56 
 
 
Means Comparisons 
Comparisons for all pairs using Tukey-Kramer HSD 
Confidence Quantile 
q* Alpha 
2.34688 0.05 
 
LSD Threshold Matrix 
Abs(Dif)-HSD 2 3 1 
2 -0.03553 0.01110 0.04754 
3 0.01110 -0.04624 -0.00984 
1 0.04754 -0.00984 -0.04563 
 
Positive values show pairs of means that are significantly different. 
 
Connecting Letters Report 
 
Level             Mean 
70-90 A       0.17859510 
40-60   B     0.12626263 
1-30   B     0.09016393 
 
Levels not connected by same letter are significantly different. 
 
Ordered Differences Report 
Level  - Level Difference Std Err Dif Lower CL Upper CL p-Value  
2 1 0.0884312 0.0174254 0.047536 0.1293264 <.0001* 
2 3 0.0523325 0.0175709 0.011096 0.0935692 0.0083* 
3 1 0.0360987 0.0195741  -0.009839 0.0820366 0.1558 
 
 
